VANGUARD PRIMECAP FUND
VANGUARD CHESTER FUNDS · Series S000002568 · 2 share classes
data updated 2026-09-08
Fund profile
As filed in the prospectus · 2026 Q1
Vanguard PRIMECAP Fund (the Fund) seeks to provide long-term capital appreciation.
The fund pursues active management, selecting large- and mid-capitalization stocks that managers believe offer above-average earnings growth potential not yet reflected in market prices. The fund may allocate up to 25% of assets to foreign securities, including depositary receipts traded on U.S. or foreign markets.
| Share class | Expense ratio |
|---|---|
| VPMCX | 0.35% |
| VPMAX | 0.27% |
Portfolio turnover 11.00% · as of 2026 Q1
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 98.46% |
| Cash & short-term | 1.63% |
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +48.06% | +93.55% | +91.08% | 17.03% | -7.86% | |
| +48.18% | +93.97% | +91.77% | 17.02% | -7.85% |
These classes hold the same portfolio, so the 0.69pp spread over 5 years is the cost difference between them — roughly 0.14pp a year — not a difference in what they own.
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| MU | Micron Technology IncMU | 13.50% | $1,154.29 | $12.97B | 11.2M |
| INTC | Intel CorpINTC | 6.79% | $139.63 | $6.53B | 46.8M |
| LLY | Eli Lilly & CoLLY | 6.76% | $1,199.43 | $6.49B | 5.4M |
| KLAC | KLA CorpKLAC | 3.85% | $301.71 | $3.70B | 12.2M |
| GOOGL | Alphabet IncGOOGL | 3.52% | $357.37 | $3.39B | 9.5M |
| — | AstraZeneca PLC | 2.35% | $189.62 | $2.26B | 11.9M |
| NVDA | NVIDIA CorpNVDA | 2.33% | $200.09 | $2.24B | 11.2M |
| AMZN | Amazon.com IncAMZN | 2.05% | $238.34 | $1.97B | 8.3M |
| TSLA | Tesla IncTSLA | 1.89% | $420.60 | $1.81B | 4.3M |
| BIIB | Biogen IncBIIB | 1.88% | $216.06 | $1.81B | 8.4M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 44.91% of net assets, top 25 66.30%, across 171 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free